Phibro Animal Health Corp
- Last sale
- Nov 12, 2026 · +0.75%
- Market cap
- $1.44B
- 40.6M shares
- Filings
- 774
Q1 2027+17.1% FY26 yoy
Q1 2027+106.6% FY26 yoy
Q1 2027+76.0% FY26 yoy
Q1 2027derived−76.4% FY26 yoy
Q1 2027+104.2% FY26 yoy
Q1 2027−9.7% FY26 yoy
- $1.44B
- 14.0×
- 0.9×
- 3.4×
- 1.51%
- 1.35%
Twelve months to Sep 30, 2026 · derived
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $1,518,093,000 | reported | |
| FY 2025 | 2025-06-30 | $1,296,215,000 | reported | |
| FY 2024 | 2024-06-30 | $1,017,679,000 | reported | |
| FY 2023 | 2023-06-30 | $977,889,000 | reported | |
| FY 2022 | 2022-06-30 | $942,261,000 | reported | |
| FY 2021 | 2021-06-30 | $833,350,000 | reported | |
| FY 2020 | 2020-06-30 | $800,354,000 | reported | |
| FY 2019 | 2019-06-30 | $827,995,000 | reported | |
| FY 2018 | 2018-06-30 | $819,982,000 | reported | |
| FY 2017 | 2017-06-30 | $764,281,000 | reported | |
| FY 2016 | 2016-06-30 | $751,526,000 | reported | |
| FY 2015 | 2015-06-30 | $748,591,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | $19.46M | — | $19.46M | $0.48 | — | — | 197.3% |
| FY2025 | $19.45M | — | $19.45M | $0.48 | — | — | 46.5% |
| FY2024 | $19.44M | — | $19.44M | $0.48 | — | — | 41.9% |
| FY2023 | $19.44M | — | $19.44M | $0.48 | — | — | — |
| FY2022 | $19.44M | — | $19.44M | $0.48 | — | — | — |
Segments
LineFY2026ShareChange
Animal Health$1.16B77%+20.7%
Mineral Nutrition$282.34M19%+11.5%
Performance Products$73.53M4.8%−8.3%
Total$1.52B
Pharmaceutical preparations
Phibro Animal Health Corp is the 29th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SRPTSarepta Therapeutics, Inc.$2.2B15.6%32.5%$1.7BPTCTPTC Therapeutics, Inc.$1.7B114.5%39.4%$5.3B
PAHCPhibro Animal Health Corp (this company)$1.5B17.1%6.6%$1.4B
ALKSAlkermes plc.$1.5B5.2%16.4%$7.9BSUPNSupernus, Inc.$1.2B4.3%16.9%$3.4BNSRXNasus Pharma Ltd$1.2B—0.5%$26.6MPBHPrestige Consumer Healthcare Inc.$1.1B4.3%17.5%$2.1BACADAcadia Pharmaceuticals Inc$1.1B11.9%36.5%$3.7BLEGNLegend Biotech Corp$1.0B64.0%28.8%$3.4BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Phibro Animal Health Corp · CIK 1069899 · Engraved from SEC EDGAR